Search results for: Determining Value
Filter search results
Multi-indication Pricing: Pros, Cons and Applicability to the UK
1 October 2015
…medicines are to reflect their value, then multi-indication medicines should have different prices across major indication, reflecting different values. Multi-indication pricing (MIP) involves setting a different price for each major…
The Expanding Value Footprint of Oncology Treatments
1 May 2014
…and Aetna, a private health insurance company in the US. These three were selected to suggest how assessment approaches might differ in interpreting value. The value of a particular medicine,…
The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis
30 June 2022
…early dialogue; to discuss unmet needs of the disease, and the value that a novel treatment could bring to patients and healthcare systems. As part of MoCA, the Transparent Value…
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals
1 July 2018
The current system of a single price per medicine means that, for multi-indication medicines, the relationship between price and “value” can vary substantially. In this OHE Research paper, we consider:…
A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold
1 July 2020
…economic value of new medicines between consumers (payers) and developers (life science… This paper presents a supply and demand model of pharmaceutical markets to analyse the relationship between the value…
OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data
16 January 2017
Professor Andrea Manca from the University of York will lead an OHE Lunchtime Seminar on 13th February 2017 on the topic of economic evaluation for decision-making and the value of…
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017
31 October 2017
…in an HTA review are: the insurance value of protection from outbreaks; the diversity value of using alternative available antibiotics; the value of a diagnostic to anticipate the use of…
OHE at HESG Winter 2018
4 January 2018
…van Hout Summary: The 2017 English EQ-5D-5L value set differs substantially from the 1997 UK EQ-5D-3L value set recommended by NICE. Given the implications of using the 5L value set…
EQ-5D-5L Value Set for England Study Team Responds to the EEPRU Review
29 November 2018
…and Social Care (DHSC) to undertake a review of the EQ-5D-5L value set for England given the policy relevance of the EQ-5D-5L. The EEPRU review of the value set has…